RMD - ResMed Inc.

NYSE - NYSE Delayed Price. Currency in USD
160.57
-0.16 (-0.10%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close160.73
Open160.98
Bid145.13 x 800
Ask160.61 x 800
Day's Range160.24 - 161.98
52 Week Range90.64 - 161.98
Volume433,868
Avg. Volume505,534
Market Cap23.088B
Beta (5Y Monthly)0.42
PE Ratio (TTM)55.37
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.56 (0.97%)
Ex-Dividend DateNov. 04, 2019
1y Target EstN/A
All
News
Press Releases
  • Business Wire

    RESMED ALERT: Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of ResMed, Inc. and Encourages Investors to Contact the Firm

    Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against certain officers and directors of ResMed, Inc. (NYSE: RMD) on behalf of long-term stockholders.

  • Business Wire

    Robbins LLP Is Investigating the Officers and Directors of ResMed Inc. (RMD) on Behalf of Shareholders

    Shareholder rights law firm Robbins LLP is investigating whether certain officers and directors of ResMed Inc. (NYSE: RMD) breached their fiduciary duties to shareholders. ResMed develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing.

  • Business Wire

    ResMed to Report Second Quarter Fiscal 2020 Earnings on January 30, 2020

    ResMed (NYSE: RMD) (ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2020 on Thursday, January 30, 2020, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.

  • Business Wire

    ResMed Announces Participation in the 38th Annual J.P. Morgan Healthcare Conference

    ResMed (NYSE: RMD, ASX: RMD) today announced that Mick Farrell, chief executive officer, will present at the 38th Annual J.P. Morgan Annual Healthcare Conference on Monday, January 13, 2020, beginning at approximately 8:30 a.m. (Pacific Standard Time) at Westin St. Francis in San Francisco, CA.

  • GlobeNewswire

    Globus Medical Announces Board of Director Addition and Departure

    Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the appointment of Robert Douglas to the Company’s Board of Directors, and the departure of Board member Kurt Wheeler, effective December 11, 2019. Mr. Wheeler has assumed a role that precludes him from serving on public company Boards. Mr. Douglas has nearly thirty years of experience in medical device technology, with particular expertise in digital health.

  • Business Wire

    COPD Outcomes Improved Significantly When Patients and Doctors Used a Digital Health Tool, Propeller Health Study Finds

    Patients with chronic obstructive pulmonary disease (COPD) at Louisville’s JenCare Senior Medical Center, a ChenMed company, saw their health outcomes improve significantly when their primary care physicians (PCPs) encouraged using Propeller’s digital health tool to manage their COPD, reports new research by Propeller Health, JenCare, ChenMed, and the Center for Healthy Air, Water and Soil investigators published in JMIR Formative Research.

  • Propeller Health Users Can Now Access Pharmacy Services From CVS, Walmart, Kroger and Rite-Aid From Within the Propeller App
    Business Wire

    Propeller Health Users Can Now Access Pharmacy Services From CVS, Walmart, Kroger and Rite-Aid From Within the Propeller App

    With the expansion of the My Pharmacy feature, patients can use Propeller to refill prescriptions with five of the seven largest pharmaceutical providers in the U.S. Propeller Health, a leading digital health company dedicated to the management of asthma and chronic obstructive pulmonary disease (COPD), today announced that users are now able to access pharmacy services from CVS, Walmart, Kroger and Rite-Aid directly from the Propeller app. In January 2019, Propeller announced the launch of My Pharmacy, an in-app feature that allows users to manage their prescription refills for asthma and COPD and locate a nearby pharmacy from the Propeller app.

  • Business Wire

    ResMed Announces Participation in the Credit Suisse 28th Annual Healthcare Conference

    ResMed today announced that Rob Douglas, chief operating officer, will present at the Credit Suisse 28th Annual Healthcare Conference on Tuesday, November 12, 2019, beginning at approximately 9:10 a.m.

  • Propeller Users Can Now Locate Their Lost Inhaler by “Ringing” Their Propeller Sensor From the App
    Business Wire

    Propeller Users Can Now Locate Their Lost Inhaler by “Ringing” Their Propeller Sensor From the App

    Starting today, Propeller users will be able to “ring” the sensor on a misplaced inhaler to make it easier to find, through an update to the Find My Inhaler feature in the Propeller app. Propeller is a digital health tool that helps people with asthma or COPD manage their breathing. Propeller sensors connect to patients’ existing inhalers and transmit data on medication use and health patterns to the Propeller app on patients’ smartphones.

  • Business Wire

    ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2020

    SAN DIEGO-- -- Year-over-year revenue grows 16%, non-GAAP operating profit up 22% Balanced growth across product portfolio and global markets Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com ResMed Inc. , a world-leading connected health company, today announced results for its quarter ended September 30, 2019. First Quarter 2020 Highlights ...

  • ResMed Introduces AirFit N30, World’s First Tube-Down Nasal Cradle CPAP Mask
    Business Wire

    ResMed Introduces AirFit N30, World’s First Tube-Down Nasal Cradle CPAP Mask

    ResMed (RMD) (RMD.AX) today introduced AirFit N30, the world’s first tube-down nasal cradle CPAP mask with a front-facing tube – a brand-new option for sleep apnea treatment. ResMed’s lightest mask yet, AirFit N30 features an adjustable elastic headgear, plus a nasal cradle cushion that sits under the nasal bridge, eliminating soreness in that area. Together, these innovations help make starting and staying on CPAP therapy easier than ever for more of the 936 million people worldwide living with sleep apnea.

  • Business Wire

    New Research Reveals Updated Patient Preferences on Digital Health Technology

    The survey highlights a reason for optimism that the markets for digital health technology will only continue to grow. The survey of a nationally representative sample of 3,000 Americans, conducted in partnership with Edelman Intelligence, revealed that the use of – and confidence in – remote digital health technology is widespread: 56% of those surveyed currently monitor their health with at least one digital data collection tool. Perhaps more surprising, remote digital health technology seems to have deepened people’s connection with their physicians rather than distanced them from one another.

  • GlobeNewswire

    Cerner and ResMed Join Forces to Connect Health Networks and the Home

    Cerner Corporation (CERN), a global health platform and innovation company, and ResMed (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced a new collaboration agreement to help providers make more informed treatment decisions, control costs and deliver seamless care across health systems to the home. To address this trend, Cerner designated ResMed’s Brightree Home Health and Hospice platform as its preferred solution in the space to integrate with its Cerner Millennium® electronic health record (EHR).

  • Business Wire

    ResMed to Report First Quarter Fiscal 2020 Earnings on October 24, 2019

    ResMed today announced it plans to release financial and operational results for the first quarter of fiscal year 2020 on Thursday, October 24, 2019, after the New York Stock Exchange closes.

  • GlobeNewswire

    MatrixCare Appoints Geriatrician Dheeraj Mahajan as Chief Medical Officer, Executive Vice President

    MatrixCare announced today that Dheeraj Mahajan, MD, MBA, MPH, FACP, CMD, CIC, CHCQM, has joined its team as chief medical officer and executive vice president to advance MatrixCare’s vision of creating a seamless continuum where data moves with the patient, connecting both acute and post-acute care providers. Dr. Mahajan joins MatrixCare with more than 15 years as a practicing physician and is a nationally recognized expert and speaker on physician payment models, clinical documentation improvement, denial management, quality measurement in post-acute and long-term care, and transitional care quality improvement.

  • GlobeNewswire

    Evolus Expands Board of Directors with Appointment of Independent Directors Peter Farrell, Ph.D. and Karah Parschauer, J.D.

    NEWPORT BEACH, Calif., July 15, 2019 -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,.

  • Business Wire

    New Analysis Shows Sleep Apnea More Common in Americas than Previously Thought

    ResMed (RMD) (RMD.AX) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented at the annual SLEEP meeting hosted by the American Academy of Sleep Medicine (AASM) and the Sleep Research Society.

  • Business Wire

    ResMed Appoints New South Asia General Manager to Help Drive Increased Awareness and Treatment of Sleep Apnea, Other Respiratory Diseases

    ResMed, a world leader in connected health solutions for sleep apnea, lung disease, and other chronic diseases, today announced the appointment of Shubhi Khurana as general manager for India and South Asia.